Literature DB >> 11879264

Restoration of erythropoiesis by rituximab in an adult patient with primary acquired pure red cell aplasia refractory to conventional treatment.

Holger W Auner, Albert Wölfler, Christine Beham-Schmid, Dirk Strunk, Werner Linkesch, Heinz Sill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11879264     DOI： 10.1046/j.1365-2141.2002.3317_3.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  11 in total

Review 1.  Anemia of Central Origin.

Authors:  Kazusa Ishii; Neal S Young
Journal:  Semin Hematol       Date:  2015-07-09       Impact factor: 3.851

2.  Idiopathic pure red cell aplasia: first report on CD8 positive lymphocytosis in bone marrow biopsy sections.

Authors:  K M A Ramadan; J A M Anderson; M F McMullin; G M Markey
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

Review 3.  Pure red cell aplasia.

Authors:  Robert T Means
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

4.  [How I diagnose and treat pure red cell aplasia].

Authors:  B Han
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

5.  Occurrence of acute pulmonary embolism induced by recombinant erythropoietin during treatment of pure red cell aplasia associated with thymoma: A case report.

Authors:  Xiangli Cui; Zirui Wan; Zhuo Ma; Lihong Liu; Yuanhua Yang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

6.  Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report.

Authors:  Caroline M Behler; Norah A Terrault; Joan E Etzell; Lloyd E Damon
Journal:  J Med Case Rep       Date:  2009-07-06

Review 7.  B cell depletion in autoimmune disease.

Authors:  Claire Gorman; Maria Leandro; David Isenberg
Journal:  Arthritis Res Ther       Date:  2003-10-02       Impact factor: 5.156

8.  Rituximab: A viable treatment option for epoetin-induced pure red cell aplasia.

Authors:  S A Mahajan; N Nandagopal; M Soni; R A Annigeri
Journal:  Indian J Nephrol       Date:  2015 Nov-Dec

9.  Rational management approach to pure red cell aplasia.

Authors:  Suresh Kumar Balasubramanian; Meena Sadaps; Swapna Thota; Mai Aly; Bartlomiej P Przychodzen; Cassandra M Hirsch; Valeria Visconte; Tomas Radivoyevitch; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2017-12-07       Impact factor: 9.941

10.  Pure Red Cell Aplasia with Del(20q) Sensitive for Immunosuppressive Treatment.

Authors:  Anh Khoi Vo; Hilde Kollsete Gjelberg; Randi Hovland; Marte Karen Lindstad Brattås; Øystein Bruserud; Håkon Reikvam
Journal:  Case Rep Hematol       Date:  2020-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.